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Abstract Bone conduction devices (BCDs) are advo-
cated as an amplification option for patients with congen-
ital conductive unilateral hearing loss (UHL), while other
treatment options could also be considered. The current
study compared a transcutaneous BCD (Sophono) with a
percutaneous BCD (bone-anchored hearing aid, BAHA) in
12 children with congenital conductive UHL. Tolerability,
audiometry, and sound localization abilities with both types
of BCD were studied retrospectively. The mean follow-up
was 3.6 years for the Sophono users (n = 6) and 4.7 years
for the BAHA users (n = 6). In each group, two patients
had stopped using their BCD. Tolerability was favorable
for the Sophono. Aided thresholds with the Sophono were
unsatisfactory, as they did not reach under a mean pure
tone average of 30 dB HL. Sound localization generally
improved with both the Sophono and the BAHA, although
localization abilities did not reach the level of normal
hearing children. These findings, together with previously
reported outcomes, are important to take into account when
counseling patients and their caretakers. The selection of a
suitable amplification option should always be made
deliberately and on individual basis for each patient in this
diverse group of children with congenital conductive UHL.
Keywords Transcutaneous implant  Percutaneous
implant  BAHA  Bone-anchored hearing implant 
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Introduction
Several studies have demonstrated delays in development
and school performance in children with unilateral hearing
loss (UHL) compared to children with normal hearing [1–
3]. A specific condition of UHL is congenital conductive
UHL, which is often caused by anatomical anomalies, such
as aural atresia and/or ossicular chain anomalies. These
relatively rare abnormalities affect approximately one in
10,000 live births [4]. Depending on the severity of the
anomaly, several treatment options are to be considered in
children presenting with such altered anatomy: surgical
correction of the anomaly if feasible, amplification by
means of a conventional hearing aid if possible or a bone
conduction device (BCD) in all other cases, or conserva-
tively monitoring the child’s development. When inter-
vention is required, amplification of sound by means of a
percutaneous BCD is associated with better audiological
outcome than surgical intervention, especially in patients
with considerable anatomic deviations [5–7].
In 2011, a new passive transcutaneous BCD (Sophono
Alpha 1) has been introduced [8]. The Sophono provides
hearing amplification through an intact skin due to mag-
netic coupling, in contrast to the well-established percuta-
neous BCDs, most commonly known as bone-anchored
hearing aids (BAHA), currently marketed as Cochlear’s
Baha system and Oticon Medical’s Ponto system. In a
previous study [9], six children with congenital conductive
UHL who used the Sophono were compared with six
children with congenital conductive UHL who used a
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BAHA. The BAHA was more powerful; measurements
with a skull simulator indicated a 10 dB higher output than
with the Sophono. Furthermore, patients who used a
BAHA demonstrated better aided thresholds than those
using a Sophono. Another study reported that aided
thresholds in patients using the Sophono were comparable
to those of the same patients using a BCD on a softband
[10]. Implant loss and soft tissue problems are expected to
be encountered less frequently with the Sophono. This is
especially relevant for the application of BCDs in children,
as it is reported that children using a BAHA with a pre-
vious generation implant experience more complications
and implant losses compared to adults [11]. However, it
should be noted that, owing to new and wider diameter
implant designs, soft tissue reactions of BAHAs have
decreased significantly in adults [12, 13], while implant
survival increased in the pediatric population [14].
In the current study, we report on soft tissue tolerability,
hearing results, and sound localization abilities of the same
six patients with congenital conductive UHL implanted
with the Sophono, that have been described in a previous
study [9]. The outcomes are compared to a group of six
children with congenital conductive UHL that use a
BAHA. The audiometric outcome of an updated version of
the sound processor (Alpha 2) was investigated. Sound
localization was tested elaborately.
Methods
Ethical considerations
Assessment by the local ethics committee was not required
as the application of BCDs is a regular health care treat-
ment option in the Netherlands. Furthermore, all testing
data were used in retrospect and part of regular follow-up
measurements, which were used to optimize outcomes with
the respective BCDs.
Patients and BCDs
Retrospectively, the follow-up data of the same six patients
implanted with the Sophono who participated in a previous
study [9] were gathered. Five patients (patients 1–5) suf-
fered from high-grade unilateral congenital aural atresia
type IIb or III (according to Cremers’ classification [15])
and one patient suffered from a congenital ossicular chain
anomaly (patient 6), resulting in severe conductive hearing
loss in the impaired ear. The contralateral, anatomically
unaffected ears had near normal hearing thresholds. In all
cases, surgery was not considered to be a suitable treatment
option. The caretakers of the patients were given the pos-
sibility to choose the Sophono instead of the BAHA after
elaborate counseling. Outcomes were compared to six
patients with aural atresia type III that used a BAHA who
also participated in the same previous study [9].
The Sophono Alpha 1 (Sophono, Inc., Boulder, CO,
USA; recently acquired by Medtronic, Inc., Fridley, MN,
USA) is a BCD that is magnetically coupled to surgically
implanted double magnets through an intact skin. Implant
surgeries were performed between April 2010 and
December 2011. The applied surgical technique has been
described in detail [8]. Recently, the sound processor was
updated (Alpha 2) and aided thresholds with this new
sound processor were tested in the current manuscript. The
even more recent Alpha 2 MPO was not yet made available
to the study population at the time of the measurements.
All patients in the BAHA group were implanted with the
Baha 3.75-mm-diameter flange fixture (Cochlear Bone
Anchored Solutions AB, Mo¨lnlycke, Sweden). Implant
surgery was performed between October 2008 and October
2011 according to the Nijmegen linear incision technique
[16] and in two phases for all patients under 10 years old. The
Divino sound processor was used by five patients (patients 7,
8, 10, 11, and 12) and the BP100 by one patient (patient 9).
Tolerability and appreciation
During regular follow-up visits of at least one visit per
year, the local soft tissue status was monitored. Skin
reactions were recorded according to Holgers’ classifica-
tion [17]. Furthermore, information on the actual usage of
the device was surveyed, i.e., frequency and duration of the
wearing time, and general satisfaction was enquired.
Audiometry
The patients with the Sophono underwent audiometric
evaluation for the aided condition with the first-generation
(November 2012) and the updated sound processor (May
2013). For the BAHA patients there were no more recent
data available compared to those previously reported [9].
Aided pure tone audiometry (at 0.5, 1, 2, and 4 kHz) and
speech audiometry data, viz., speech recognition threshold
(SRT) and word recognition score (WRS) at 65 dB HL,
were collected with the update fittings. All audiometric
tests were conducted in the sound field with the normal ear
plugged and covered with an earmuff. Baseline audiometry
was performed with headphones.
Sound localization
Sound localization was tested with the minimum audible
angle test (MAA; see Dun et al. [18]) and with a local-
ization setup described by Agterberg et al. [19, 20]. The
MAA test was used to examine the minimal angle at which
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two speakers could be discriminated. In this test, the
patients were seated comfortably in a chair in a sound-
attenuated booth, with two speakers at 90 azimuth left and
right. A broadband noise burst of 0.3 s with roved ampli-
tudes was randomly presented from one of both speakers. If
the subject identified the speaker from which the stimulus
was presented, the angle was changed to 60 azimuth. If
sounds were again identified properly, the angle was fur-
ther reduced (subsequently to 30, 15, 10, and 5). The
smallest angle at which all sounds are identified correctly is
the MAA. Tests were conducted late 2011 and early 2012.
Five normal hearing children participated in the MAA as
part of school project, which provided a reference.
The MAA test provides information about the ability to
lateralize sound. To measure the localization abilities of the
patients we applied another test setup. Broadband noise
stimuli (0.5–20 kHz; n = 36) were presented in a com-
pletely dark, sound-attenuated room, to ensure that patients
could only use acoustic information to localize sounds.
Sound levels ranged between 45 and 65 dB SPL in
broadband and duration of all stimuli was 150 ms. The
subjects indicated the direction of the sound (ranging from
-85 to ?85 in azimuth) by means of head movement
(magnetic search-coil induction technique) with a laser
pointer mounted on eyeglasses pointed on a small plastic
frame in front of them. The test setup [21, 22] and the
processing of the data [19, 20] are described in detail in
previous studies. Recently, this setup and the test protocol
were also used for testing sound localization in children
[20]. The outcome of this test is defined by the best linear
fit of the stimulus–response relationship on the azimuth
data, which is derived from the following formula:
aRESP ¼ bþ g  aSTIM
in which a is the azimuth angle (in degree), b is the response
bias (in degree), and g the response gain (dimensionless).
Furthermore, themean absolute error (MAE)was calculated.
Tests were conducted over the course of 2012 and 2013.
Results
Tolerability and appreciation
No complications occurred during surgery. The surgery
time for the Sophono was slightly longer compared to the
BAHA implantation, however, consisted of a one-stage
procedure, compared to a two-stage procedure in most
BAHA patients. The mean follow-up of the patients with
the Sophono at the time of the retrospective data analysis
was 3.6 years (range 3.1–4.7 years). Two of the six
patients stopped using their device: patient 2 after
approximately 1.5 years because of cosmetics and patient 6
after approximately 3 years because she experienced too
little audiological benefit. All other patients reported to use
their device predominantly at school. Few skin complica-
tions were reported. Some patients experienced minor
discomfort due to pressure after wearing the device con-
tinuously, which was quickly resolved after removing the
sound processor for a short time. At physical examination
during regular follow-up visits to our clinic, once a crust on
the skin at the implant site was detected, without the patient
experiencing any symptoms. The surrounding skin was not
infected. Therefore, this was treated conservatively with
fusidic acid cream for a week. No implant loss, serious skin
infections, or reasons for revision surgery were encoun-
tered. One patient underwent an abdominal MRI scan (1.5
tesla) without complications at the implant site. Overall the
remaining four patients reported positively on the benefit
they experienced when using the device.
The mean follow-up of the patients in the BAHA group
was 4.7 years (range 3.2–5.9 years). Just like in the
Sophono users, two children stopped using the device.
Moreover, they had their implant or abutment removed,
both after 4.5 years. They reported to experience too little
hearing benefit. Another patient was lost to follow-up, as
he moved to China and we were not able to check whether
he was still using the device. Besides the previously
reported re-implantation in one patient [9] and one patient
that presented with postoperative hematoma, five patients
experienced at least mild soft tissue reactions (Holgers
grade 1) at some point during follow-up. Two patients
presented with Holgers grade 2 soft tissue reactions at
some time during follow-up that were easily and conser-
vatively treated with antibiotic ointment. One patient
reported soft tissue reactions to occur four times a year
during follow-up over telephone. These reactions could not
be specified to a Holgers grade, as she did not visit our
clinic for evaluation and treatment of each soft tissue
reaction, yet did not request treatment on the other hand.
Audiometry
Table 1 presents audiometry details for all tested patients.
At the time of these audiometrical evaluations, patient 2
already quit using the device. The aided audiometry with
the first-generation sound processor (Alpha 1) was con-
ducted at a mean follow-up time of 1.5 years (range
1.0–2.6 years) and the measurements with the second-
generation sound processor (Alpha 2) were performed
approximately 6 months later. The measurements with the
first-generation sound processor differ slightly from earlier
reported outcome [9], measured shortly after implantation,
also due to updated fitting software. As illustrated by
Table 1, audiometry results with either generation sound
processor are comparable.
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Sound localization
The MAA-results in Table 2 show better aided than unai-
ded scores for both the Sophono users and the BAHA
users. Three of the Sophono users already displayed good
unaided MAA scores, which did not improve in the aided
condition. All BAHA users showed improvement from
their poor unaided scores, although they did not all meet
the scores of the Sophono users. All normal hearing chil-
dren reached the smallest possible MAA of 5.
Figure 1 shows the stimulus response relationships of
five of the Sophono users (left column) and five of the
BAHA users (right column). The individual plots demon-
strate that all BCD users’ sound localization abilities
improved in the aided condition as compared to the unai-
ded condition; the aided data plots approach the diagonal
more closely than the unaided data plots. However, patient
6 showed only a small improvement because the unaided
localization ability was already reasonable good. Despite
the clear improvement of the localization abilities of
patient 4, this patient demonstrated lateralization instead of
localization of the stimuli.
In Fig. 2, for each of the patients the aided gain and
MAE are plotted against the unaided values. This fig-
ure demonstrates the improvement in the aided condition
compared to the unaided condition, since the data points
are below the diagonal in the gain plot (gain in the aided
condition is closer to 1 than the gain in the unaided con-
dition) and the data points in the MAE plot are above the
diagonal (i.e., smaller, thus, better MAE in the aided
condition than in the unaided condition).
Table 1 Patient characteristics and audiometry data of the affected ear
Patient Age Gender Atresia BCD Baseline Aided (previously
reported [9])
Aided (first
generation,
updated fitting
software)
Aided (second
generation)
PTA
AC
PTA
BC
SRT WRS PTA SRT WRS PTA SRT WRS PTA SRT WRS
1 5 M IIB/III AD Sophono 56 11 67 0 40 29 92 29 22 97 24 25 90
2 10 F III AS Sophono 61 0 60 0 30 27 92 n.a n.a n.a n.a. n.a. n.a.
3 6 M III AD Sophono 63 4 n.a. n.a. 35 29 90 25 15 100 23 25 93
4 5 M III AS Sophono 60 4 65 0 41 31 72 31 34 70 41 n.a. n.a.
5 11 M IIIAD Sophono 54 9 n.a. n.a. 36 29 90 35 27 90 34 27 92
6 7 F OCA AS Sophono 53 11 38 92 36 35 70 35 25 100 36 27 90
Mean 7 58 7 58 23 36 30 84 31 25 91 32 26 91
7 8 M III AS Divino 68 9 65 0 38 30 90
8 9 M III AS Divino 66 13 63 0 39 30 92
9 10 F III AS BP100 74 14 53 10 24 23 97
10 6 M III AS Divino 78 20 70 0 35 12 96
11 8 M III AD Divino 61 9 63 0 n.a. 25 78
12 8 F III AD Divino 69 10 70 0 30 20 92
Mean 8 69 12 64 2 33 23 91
These data have partially been published earlier in Hol et al. [9]
Age Age at implant surgery; gender:M male; F female; AD right ear; AS left ear; OCA ossicular chain anomaly; PTA pure tone average in dB HL
at 0.5, 1, 2, and 4 kHz; AC air conduction; PTA BC mean bone conduction thresholds in dB HL at 0.5, 1, 2, and 4 kHz; SRT speech recognition
threshold in dB HL; WRS word recognition score at 65 dB HL in percent; n.a. data not available
Table 2 The outcomes of the
minimum audible angle (MAA)
test
Patient Unaided Aided
1 15 15
2 15 15
3 90 20
4 90 15
5 90 10
6 10 10
Mean 52 14
7 90 15
8 90 30
9 60 10
10 60 20
11 90 30
12 90 30
Mean 80 23
Normal hearing children all
scored a MAA of 5. Patient
numbers correspond to the data
in Table 1
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Discussion
In the current study, we presented data obtained with at
least three years of follow-up on a population with con-
genital conductive UHL who were rehabilitated with either
a Sophono or a BAHA. The first audiological comparison
between these BCDs in the same patients was reported
previously [9]. Four out of six patients implanted with the
Sophono were still using their device after a mean follow-
up time of 3.6 years, mainly at school. The same applies to
the BAHA users at a mean follow-up of 4.7 years, although
one patient’s use could not be confirmed. Soft tissue tol-
erability with the Sophono was favorable. Subjective
appreciation of the users was comparably reasonable. The
updated second-generation transcutaneous sound processor
(Alpha 2) provided similar hearing outcome compared to
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Fig. 1 The outcomes of the sound localization test. Localization abilities in the unaided condition are compared to the aided condition using
either the Sophono or the BAHA. Patient numbers correspond to the data in Table 1
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the first-generation sound processor (Alpha 1). To evaluate
binaural restoration, sound localization was tested. Both
groups of BCD users showed improvement in sound
localization compared to the unaided situation.
The main strengths of the current study are the homo-
geneous populations and the relatively long follow-up
compared to other studies, which is discussed in the next
section. Furthermore, unique data concerning sound
localization are presented. Sound localization is considered
a major outcome measure of this intervention. The limi-
tations of the current study are the small study populations
with high dropout rates. Besides, the retrospective study
design is methodologically weaker than a prospective
(randomized controlled) clinical trial would have been.
The first case series that have been published on the
Sophono studied populations with diverse types of hearing
loss. Some case series present data of populations with both
conductive and mixed hearing loss [23, 24] while others
provide only concise audiometry data [25, 26]. Case series
that consist of patients with conductive hearing loss,
included both unilaterally and bilaterally affected patients
[10, 27–29]. Because of these mixed populations, it is hard
to substantially objectify or compare the audiological
outcomes. Soft tissue outcomes have been generally
reported positive.
Due to the regular follow-up visits and standardized
procedures with extensive audiometry and sound localiza-
tion testing, the results are considered to provide substan-
tial information on both types of BCDs. In contrast to the
literature that has already been published on the Sophono,
the current results are derived from a homogeneous pop-
ulation with a comparison population using a BAHA over a
relatively long-term follow-up period.
The clinical outcome of the current case series with the
Sophono is considered favorable to that of the BAHA when
applied in children. It has been demonstrated that 15.2 %
of the previous generation percutaneous implants are lost in
children and adverse skin reaction were found in 7.8 % of
follow-up visits, which is considerably lower in adults [11].
Arguably, in adult patients, skin reactions with percuta-
neous implants are decreasing to such low values with
updated implant designs [12, 13], that no significant dif-
ference between soft tissue tolerability between a transcu-
taneous and percutaneous BCD is to be expected.
Furthermore, in children, implant survival is reported to
increase with these new implants: implant loss of 3.5 % is
reported in children with the wider diameter implants [14].
In contrary, soft tissue problems with the Sophono were
encountered in another study, with 5 of 14 implants (36 %)
having significant enough difficulties to discontinue use for
a certain period [26].
Only four of the original six implanted patients in either
group were still using their BCD. It has recently been found
that long-term compliance with a BCD (although percuta-
neously applied in that study) in congenital conductive
UHL patients was disappointing [30]. However, follow-up
time in the current study is shorter and the study population
is considerably smaller. Nevertheless, it could therefore be
speculated that this specific indication is a challenging
handicap to maintain satisfaction and device use over time.
Aided threshold in pure tone audiometry were around
30 dB HL in the affected ears, despite extensive fitting and
testing in case of the Sophono group. These outcomes are
comparable to the results of another study with a compa-
rable population [29]. We did not perform additional
audiometry in the BAHA group compared to the previous
report on this population. However, these aided thresholds
were also not as good as we had expected, especially
concerning the outcomes with the skull simulator [9].
Nevertheless, the BAHA group showed larger improve-
ment in hearing compared to the Sophono group. We
consider these thresholds unsatisfactory; in patients with
normal cochlear function aided thresholds with a properly
functioning BCD should ideally be around 10–20 dB HL
BAHA
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Fig. 2 Comparison of the gain
and the MAE of the sound
localization test in the aided
condition to the unaided
condition. Concerning gain: 0
corresponds to no sound
localization, whereas 1
corresponds to perfect
localization. Concerning MAE:
this represents the mean
absolute difference between the
target position and the actual
response
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[6, 31]. As a result, the use of head shadow, binaural
squelch, and binaural summation might be below expected
values.
Sound localization is an important feature of binaural
hearing [32]. Treatment of conductive UHL ideally provides
access to binaural cues. Generally, the present outcomes
demonstrated good aided localization abilities in both tests.
However, in adults with acquired conductive UHL the
application of a BAHA improves sound localization more
clearly [19, 33]. On the other hand, remarkably good
monaural localization abilities were found in the test popu-
lation. It has been reported previously that somepatientswith
congenital conductive UHL perform well on different sound
localization tests [33, 34]. Possibly, patients with congenital
conductive UHL have developed a different strategy for
directional hearing, as they have coped with unilateral
hearing all their life. Furthermore, we cannot exclude that
longer periods of BCD use affect the directional hearing
abilities. Good MAA scores with unilateral input have also
been reported for children with bilateral conductive hearing
loss by Dun et al. [18]. Despite fair to good improvement
found in the MAA and sound localization test in the current
population, localization abilities of children treated with a
BCD for congenital conductive UHL do not reach the
localization abilities of children with normal hearing [20].
Conclusion
After at least 3 years of follow-up, soft tissue tolerability
was favorable in children implanted with a Sophono
compared to a BAHA. Aided thresholds with the Sophono
were judged unsatisfactory, also with the updated second-
generation sound processor. Sound localization improved
with either BCD in these children with congenital con-
ductive UHL, although the aided localization performance
was not as good as in normal hearing children. Although
not specifically examined in the current study, also dif-
ferences in surgery and MRI issues need to be taken into
account. The MRI compatibility of and image scattering
caused by the Sophono as well as its lower output (as
measured on a skull simulator) compared to the BAHA are
important when counseling the patient and its caretakers.
Based on the previous, the selection of a suitable amplifi-
cation option should always be made deliberately and on
individual basis for each patient, especially in this diverse
group of children with congenital conductive UHL.
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